Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for QURE

Stock NameUniqure NV
TickerQURE(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINNL0010696654

Show aggregate QURE holdings

News associated with QURE

uniQure (NASDAQ:QURE) Receives “Buy” Rating from Chardan Capital
Chardan Capital reaffirmed their buy rating on shares of uniQure (NASDAQ:QURE – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. They currently have a $35.00 target price on the biotechnology company’s stock. Several other research analysts also recently commented on QURE. Wall Street Zen raised uniQure from a “sell” rating […] - 2025-09-09 03:10:46
uniQure (NASDAQ:QURE) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of uniQure (NASDAQ:QURE – Free Report) from a sell rating to a hold rating in a report issued on Saturday morning. QURE has been the subject of several other research reports. Guggenheim reiterated a “buy” rating and issued a $28.00 price objective on shares of uniQure in a research note […] - 2025-08-05 03:00:52
uniQure N.V. (NASDAQ:QURE) Receives $37.82 Average Target Price from Analysts
uniQure N.V. (NASDAQ:QURE – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy recommendation to the company. […] - 2025-07-31 03:13:08
Analysts See 19% Gains Ahead For FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
uniQure (NASDAQ:QURE) Share Price Crosses Below Fifty Day Moving Average Following Insider Selling
Shares of uniQure N.V. (NASDAQ:QURE – Get Free Report) crossed below its fifty day moving average during trading on Monday after an insider sold shares in the company. The stock has a fifty day moving average of $14.29 and traded as low as $13.65. uniQure shares last traded at $13.95, with a volume of 1,978,275 […] - 2025-06-24 02:20:53
uniQure (NASDAQ:QURE) Shares Acquired by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 355.2% during the first quarter, HoldingsChannel reports. The fund owned 334,894 shares of the biotechnology company’s stock after buying an additional 261,323 shares during the period. Assenagon Asset Management S.A.’s holdings in uniQure were worth $3,550,000 at the end of the […] - 2025-06-16 05:08:54
uniQure (NASDAQ:QURE) Receives $37.82 Average Price Target from Analysts
uniQure (NASDAQ:QURE – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the […] - 2025-06-11 04:20:59
Bank of America Corp DE Sells 182,421 Shares of uniQure (NASDAQ:QURE)
Bank of America Corp DE cut its holdings in uniQure (NASDAQ:QURE – Free Report) by 72.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 69,064 shares of the biotechnology company’s stock after selling 182,421 shares during the period. Bank of America Corp DE’s holdings in uniQure were worth $1,220,000 as of its most recent […] - 2025-06-06 04:37:00
Stock Traders Buy Large Volume of uniQure Call Options (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors bought 8,961 call options on the company. This is an increase of 314% compared to the average volume of 2,162 call options. Institutional Inflows and Outflows Several hedge funds and other institutional investors have recently bought and sold […] - 2025-06-05 02:26:44
uniQure Sees Unusually High Options Volume (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Get Free Report) saw unusually large options trading on Wednesday. Stock traders acquired 3,615 put options on the company. This is an increase of approximately 102% compared to the average volume of 1,792 put options. Analysts Set New Price Targets QURE has been the topic of a number of research analyst reports. […] - 2025-05-23 02:01:04
uniQure (NASDAQ:QURE) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of uniQure (NASDAQ:QURE – Free Report) to a strong-buy rating in a research note issued to investors on Monday,Zacks.com reports. Cantor Fitzgerald also issued estimates for uniQure’s FY2025 earnings at ($2.76) EPS. Several other research analysts have also recently commented on QURE. HC Wainwright restated a “buy” rating and issued a […] - 2025-05-22 04:50:48
Ameriprise Financial Inc. Sells 333,968 Shares of uniQure (NASDAQ:QURE)
Ameriprise Financial Inc. decreased its holdings in shares of uniQure (NASDAQ:QURE – Free Report) by 38.6% in the fourth quarter, Holdings Channel reports. The firm owned 531,830 shares of the biotechnology company’s stock after selling 333,968 shares during the quarter. Ameriprise Financial Inc.’s holdings in uniQure were worth $9,392,000 at the end of the most […] - 2025-05-21 04:26:50
Chardan Capital Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Chardan Capital in a report released on Monday,Benzinga reports. They currently have a $38.00 price objective on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 196.64% from the stock’s previous close. QURE […] - 2025-05-14 02:56:49
uniQure (NASDAQ:QURE) Earns Buy Rating from Guggenheim
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Guggenheim in a note issued to investors on Monday,Benzinga reports. They currently have a $28.00 price target on the biotechnology company’s stock. Guggenheim’s price objective suggests a potential upside of 118.58% from the stock’s current price. A number of […] - 2025-05-14 02:56:48
uniQure (NASDAQ:QURE) Position Lowered by Stifel Financial Corp
Stifel Financial Corp reduced its position in uniQure (NASDAQ:QURE – Free Report) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,168 shares of the biotechnology company’s stock after selling 4,828 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-09 05:28:58
uniQure (NASDAQ:QURE) Short Interest Up 19.8% in April
uniQure (NASDAQ:QURE – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 5,260,000 shares, a growth of 19.8% from the March 31st total of 4,390,000 shares. Based on an average daily trading volume, of 1,380,000 shares, the […] - 2025-05-05 04:58:48
uniQure (NASDAQ:QURE) Earns “Buy” Rating from HC Wainwright
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $70.00 target price on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 386.45% from […] - 2025-04-23 02:34:42
Pre-Market Most Active for Apr 17, 2025 : HTZ, TSLL, NVDA, TQQQ, SQQQ, QURE, TSM, HIMS, NVO, UNH, BABA, NIO
The NASDAQ 100 Pre-Market Indicator is up 152.15 to 18,409.79. The total Pre-Market volume is currently 187,788,799 shares traded.The following are the most active stocks for the pre-market session: Hertz Global Holdings, Inc (HTZ) is +1.35 at $7.06, with 12,622,622 shares trade - 2025-04-17 09:28:52
Alliancebernstein L.P. Increases Stock Position in uniQure (NASDAQ:QURE)
Alliancebernstein L.P. boosted its holdings in uniQure (NASDAQ:QURE – Free Report) by 14.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 203,919 shares of the biotechnology company’s stock after acquiring an additional 25,319 shares during the quarter. Alliancebernstein L.P.’s holdings in uniQure were worth $3,601,000 as of its most recent filing with […] - 2025-04-15 04:50:49
uniQure (NASDAQ:QURE) Coverage Initiated at Chardan Capital
Equities researchers at Chardan Capital initiated coverage on shares of uniQure (NASDAQ:QURE – Get Free Report) in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $38.00 price target on the biotechnology company’s stock. Chardan Capital’s price target points to a potential upside of 257.82% from […] - 2025-04-03 04:26:59
Analysts Set uniQure (NASDAQ:QURE) PT at $38.89
Shares of uniQure (NASDAQ:QURE – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-03-28 04:56:46
uniQure (NASDAQ:QURE) Rating Increased to Sell at StockNews.com
uniQure (NASDAQ:QURE – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Tuesday. QURE has been the subject of a number of other research reports. Cantor Fitzgerald lifted their target price on shares of uniQure from $28.00 to $58.00 […] - 2025-03-13 04:26:52
uniQure (NASDAQ:QURE) Receives Buy Rating from HC Wainwright
uniQure (NASDAQ:QURE – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have a $70.00 price target on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 478.99% from the stock’s previous close. Several other equities research […] - 2025-03-06 06:56:12
William Blair Predicts uniQure’s Q1 Earnings (NASDAQ:QURE)
uniQure (NASDAQ:QURE – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of uniQure in a report released on Thursday, February 27th. William Blair analyst S. Corwin now anticipates that the biotechnology company will post earnings of ($1.48) per share for the quarter, down from their prior forecast […] - 2025-03-04 04:33:08
Y Intercept Hong Kong Ltd Lowers Stake in uniQure (NASDAQ:QURE)
Y Intercept Hong Kong Ltd lowered its stake in shares of uniQure (NASDAQ:QURE – Free Report) by 50.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,319 shares of the biotechnology company’s stock after selling 29,014 shares during the period. Y Intercept Hong Kong Ltd owned […] - 2025-03-03 06:28:55
uniQure (NASDAQ:QURE) Receives $40.00 Average Price Target from Analysts
Shares of uniQure (NASDAQ:QURE – Get Free Report) have received a consensus rating of “Buy” from the ten ratings firms that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the […] - 2025-02-06 05:00:57

iShares MSCI World Small Cap UCITS ETF USD (Acc) QURE holdings

DateNumber of QURE Shares HeldBase Market Value of QURE SharesLocal Market Value of QURE SharesChange in QURE Shares HeldChange in QURE Base ValueCurrent Price per QURE Share HeldPrevious Price per QURE Share Held
2026-01-13 (Tuesday)29,702USD 638,593QURE holding decreased by -45741USD 638,5930USD -45,741 USD 21.5 USD 23.04
2026-01-12 (Monday)29,702USD 684,334QURE holding decreased by -67721USD 684,3340USD -67,721 USD 23.04 USD 25.32
2026-01-09 (Friday)29,702USD 752,055QURE holding increased by 64454USD 752,0550USD 64,454 USD 25.32 USD 23.15
2026-01-08 (Thursday)29,702QURE holding increased by 60USD 687,601QURE holding increased by 3464USD 687,60160USD 3,464 USD 23.15 USD 23.08
2026-01-07 (Wednesday)29,642USD 684,137QURE holding increased by 22824USD 684,1370USD 22,824 USD 23.08 USD 22.31
2026-01-06 (Tuesday)29,642USD 661,313QURE holding decreased by -9485USD 661,3130USD -9,485 USD 22.31 USD 22.63
2026-01-05 (Monday)29,642USD 670,798QURE holding decreased by -22528USD 670,7980USD -22,528 USD 22.63 USD 23.39
2026-01-02 (Friday)29,642USD 693,326QURE holding decreased by -16007USD 693,3260USD -16,007 USD 23.39 USD 23.93
2025-12-31 (Wednesday)29,642USD 709,333QURE holding increased by 4446USD 709,3330USD 4,446 USD 23.93 USD 23.78
2025-12-30 (Tuesday)29,642USD 704,887QURE holding decreased by -23121USD 704,8870USD -23,121 USD 23.78 USD 24.56
2025-12-29 (Monday)29,642USD 728,008QURE holding decreased by -7410USD 728,0080USD -7,410 USD 24.56 USD 24.81
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of QURE by Blackrock for IE00BF4RFH31

Show aggregate share trades of QURE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-08BUY6023.60022.330 22.457USD 1,347 35.85
2025-12-16BUY18622.20020.000 20.220USD 3,761 39.35
2025-12-12BUY30520.00019.340 19.406USD 5,919 40.12
2025-12-01SELL-82626.95026.130 26.212USD -21,651 43.96 Profit of 14,659 on sale
2025-11-26SELL-5928.50027.290 27.411USD -1,617 45.25 Profit of 1,053 on sale
2025-11-26SELL-5928.50027.290 27.411USD -1,617 45.25 Profit of 1,053 on sale
2025-11-20BUY19229.80027.315 27.564USD 5,292 47.30
2025-11-19BUY1,92030.00026.820 27.138USD 52,105 47.88
2025-11-14SELL-23230.73028.790 28.984USD -6,724 49.67 Profit of 4,800 on sale
2025-10-29BUY11270.59070.880 70.851USD 7,935 56.70
2025-10-21BUY22463.07063.650 63.592USD 14,245 53.28
2025-10-07BUY11457.92058.660 58.586USD 6,679 51.05
2025-09-30BUY5,99258.37060.700 60.467USD 362,318 45.95
2025-09-25BUY10052.65054.980 54.747USD 5,475 17.43
2025-09-08SELL-19617.43018.170 18.096USD -3,547 0.00 Loss of -3,547 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of QURE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19318,3710552,52657.6%
2025-09-18239,7460508,30747.2%
2025-09-17250,6763,211512,40348.9%
2025-09-16226,2007,479488,78446.3%
2025-09-151,006,9078,8961,663,71860.5%
2025-09-1276,438320271,89128.1%
2025-09-1192,2600323,50328.5%
2025-09-1080,5570321,20725.1%
2025-09-09169,0780331,64351.0%
2025-09-08196,897830532,97036.9%
2025-09-05545,99401,249,60143.7%
2025-09-04128,7680375,71234.3%
2025-09-03194,7858647,01530.1%
2025-09-02134,9640585,95423.0%
2025-08-29150,7101,006258,55658.3%
2025-08-28163,0670520,91331.3%
2025-08-2783,3580179,19046.5%
2025-08-2670,5311135,86151.9%
2025-08-2567,1400139,25348.2%
2025-08-2290,341700528,21917.1%
2025-08-2186,7970420,38320.6%
2025-08-2096,859100165,46158.5%
2025-08-19122,859291270,53745.4%
2025-08-1895,3820227,46141.9%
2025-08-15184,1721,751446,15941.3%
2025-08-14158,6151,100612,14525.9%
2025-08-1395,3355,115216,40544.1%
2025-08-12153,47019,303335,01945.8%
2025-08-11421,4396,113632,51466.6%
2025-08-08104,8841,500171,55061.1%
2025-08-07128,2060245,88052.1%
2025-08-06139,9960301,27846.5%
2025-08-05204,717144757,59127.0%
2025-08-04144,8530301,26848.1%
2025-08-01129,3840304,75642.5%
2025-07-31266,949300513,12152.0%
2025-07-30531,54440,8551,489,79635.7%
2025-07-29889,60028,5591,625,47154.7%
2025-07-28178,706561252,78770.7%
2025-07-25164,3720238,94968.8%
2025-07-24202,6680363,83655.7%
2025-07-23358,7150866,42141.4%
2025-07-22272,275114472,02657.7%
2025-07-21142,9490304,01747.0%
2025-07-18338,6061,158547,74961.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy